Searched for
KURKUMBH UNIT
Are fundamental tailwinds a stronger play than volatile markets? 6 mid-cap pharma stocks with an upside potential of over 22%- Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41%
- Stocks in news: IOL Chemicals, Alkyl Amines, Ola Electric, JSW Energy, Hero MotoCorp
- Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...15 Aug, 2024, 03.07 PM IST
- USFDA issues Form 483 with 1 inspectional observation to Cipla's Kurkumbh unitA routine current Good Manufacturing Practices (cGMP) inspection was conducted by the USFDA at the company's manufacturing facility at Kurk...08 May, 2024, 03.56 PM IST
- Massive 'Meow Meow' banned drug worth over Rs 2,000 crore seized in Pune and DelhiPune police seized 1100 kg of synthetic mephedrone, also known as Meow Meow drug, during a raid in Delhi and Pune. The seized drugs is esti...21 Feb, 2024, 11.50 AM IST
- A Healthy Dose! 4 midcap pharma stocks with upside potential of up to 36%After a long period of under performance, pharma stocks have seen interest coming back from institutional investors. This is because some t...29 Aug, 2023, 12.46 PM IST
- Finally out of the woods? 4 midcap pharma stocks with an upside potential up to 34 %Pharma stocks had been underperforming for a very long time. Some time USFDA issues, at other instances of pricing pressure in US markets h...06 Aug, 2023, 12.57 PM IST
- On a path to recovery: 5 midcap pharma stocks with an upside potential up to 32%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in volatile markets. Some of them are mid-sized In...25 Apr, 2023, 01.31 PM IST
- On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...02 Mar, 2023, 01.04 PM IST
- Cipla adds capacity of captive renewable energy power plant in Maharashtra, KarnatakaThe company had commissioned 30 MWp solar project in Maharashtra's Tuljapur in January 2021, which it has further added 16 MWp of solar cap...02 Jun, 2022, 11.06 AM IST
- Long-term investors can bet on Clean Science and TechnologyAbout 65 per cent of the company's revenue is derived from performance chemicals followed by 15 per cent each from pharmaceutical intermedi...07 Jul, 2021, 06.48 AM IST
- Clean Science and Technology raises Rs 464 cr from anchor investorsAxis Capital, JM Financial and Kotak Mahindra Capital are the merchant bankers to the issue. The equity shares of the company will be liste...06 Jul, 2021, 10.36 PM IST
- Two IPOs to hit market next week; to raise over Rs 2,500 cr cumulativelyThis comes after five companies Shyam Metalics and Energy, Sona BLW Precision Forgings (Sona Comstar), Krishna Institute of Medical Science...04 Jul, 2021, 12.03 PM IST
- Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in USThe drug major is recalling esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 4...10 Jan, 2021, 12.15 PM IST
- Henkel Adhesives invests Rs 400 crores in its new production unit in India“The jobs are around 320 plus for the new facility. The unit is automated to every extent, therefore we have all skilled Jobs in there. And...04 Feb, 2020, 07.15 PM IST
- Alkyl Amines plans to set up methylamine unit at Dahejr Alkyl Amines Chemicals is planning to set up a methylamine manufacturing facility at Dahej in Gujarat with an estimated investment of Rs ...14 Oct, 2012, 02.03 PM IST
- Cipla hopeful of achieving 12-15 per cent revenue growth in FY13Pharma major Cipla Ltd today said it is hopeful of achieving 12-15 per cent revenue growth in the current financial year.17 Aug, 2012, 07.44 PM IST
- Drug cos eye US entry after FDA checksThe US drug regulator has inspected the manufacturing plants of at least half-a-dozen Indian drugmakers, raising hopes that these companies...05 Jul, 2011, 02.58 AM IST
- Cipla mops up Rs 671 cr through QIPIndian generics drug maker Cipla has raised $140 million (nearly Rs 671 crore) through a qualified institutional placement (QIP) of shares ...24 Sep, 2009, 12.40 AM IST
Load More
